Terrorist Attacks Have No Impact on DIA EuroMeeting
The EuroMeeting and Clinical Forum will take place in Paris as planned, in spite of January’s terrorist attacks in the French capital.
The EuroMeeting and Clinical Forum will take place in Paris as planned, in spite of January’s terrorist attacks in the French capital, according to the Drug Information Association (DIA).
“We are working closely with the venue and the city of Paris to make sure all security measures are taken and onsite security will be reinforced,” noted Natacha Scholl, Team Leader of Operations for DIA in Europe, Middle East & Africa. “We will put everything in place to reassure participants of course.”
She does not anticipate that the attacks will have any great impact on delegate numbers. “Registrations haven't stopped over the past days, despite the tragic events,” she remarked.
As of January 15, there were already more than 650 registered participants, and Scholl said the organizers are expecting at least 2500 to 3000 attendees in total for the two events.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
